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Abstract Glucose triggers transcriptional and post-transcrip-
tional mechanisms that increase the level and activity of
Saccharomyces cerevisiae plasma membrane H+-ATPase. We
have studied the post-transcriptional activation of the enzyme by
glucose and have found that the YOR137c gene product is
implicated in this activation. Deletion of YOR137c does not
affect the level of Pma1 at the plasma membrane, but disturbs
the glucose-triggered Vmax increase of the enzyme. We propose
that at least two independent mechanisms are involved in glucose
activation of the H+-ATPase.
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1. Introduction
The plasma membrane H-ATPase of yeast is a proton
pump that plays an essential role in the physiology of this
organism [1^4]. The activity of yeast ATPase is under strict
genetic and environmental control [5^7]; glucose is the exter-
nal signal that has been most extensively investigated. The
activity of the ATPase is controlled, at least, in two ways
by the presence of glucose in the medium. First, glucose me-
tabolism increases ATPase gene (PMA1) expression [8,9] and
second, glucose induces ATPase activation [10]. This activa-
tion results from a combined e¡ect on the kinetic parameters
of the enzyme, including Km decrease and Vmax increase [10].
The molecular mechanism of glucose-induced activation is not
known, but it is based on the elimination of an inhibitory
interaction of the C-terminus with the active site of the en-
zyme [11^13], probably mediated by Ser/Thr phosphorylation
[14] by an unknown protein kinase activity. This glucose acti-
vation of the enzyme seems to be prevented by a glucose
starvation-dependent, YCK-mediated phosphorylation of
Pma1 [15].
In an earlier study, we isolated mutations in seven genes
a¡ecting regulation of the enzyme [9]. In this report, we show
that one of these genes corresponds to YOR137c. Deletion
of YOR137c disturbs glucose activation of the ATPase by
abolishing the Vmax increase that occurs during glucose acti-
vation.
2. Materials and methods
2.1. Strains and growth conditions
Saccharomyces cerevisiae strains BWG1-7A (MATa ade1-100 his4-
519 leu2-3,112 ura3-52) [16], H114 (BWG1-7A apa7-1) [9] and its
derivatives were grown in medium with 2% glucose, 0.7% Yeast Nitro-
gen Base without amino acids (USBiologicals, Swampscott, MA) and
the appropriate requirements [17]. When indicated, medium was bu¡-
ered with 50 mM Mes adjusted to pH 6.0 with Tris (SD6.0), or with
50 mM succinic acid adjusted to pH 3.0 with Tris (SD3.0).
2.2. Cloning of the YOR137c gene
Yeast strain H114 carrying the apa7-1 mutant allele was trans-
formed [18] with 50 Wg of DNA from a Ycp50-based library [19].
Approximately 9,000 transformants were selected in SD6.0 medium.
Transformed cells were pooled and plated in SD3.0 medium. After
four days at 30‡C, two colonies grew on acidic medium and exhibited
wild type ATPase levels. Plasmids were rescued from yeast [20] and
ampli¢ed in E. coli. Restriction analysis and partial sequencing of
these clones revealed that both plasmids contained the same insert
(Fig. 1).
2.3. Deletion of YOR137c
The 3.3-kb XhoI-PstI fragment (Fig. 1) was subcloned into a
pSK(+) (Stratagene, La Jolla, CA) in which the HindIII site had
been destroyed. The resulting plasmid was cut with StuI and HindIII
and ligated with a SmaI-HindIII fragment containing the LEU2 gene
obtained from the plasmid pJJ283 [21]. The resulting plasmid was cut
with XhoI and NsiI before transformation of an autodiploid con-
structed by transformation of strain BWG1-7A with the HO gene
[22]. Integration of the vyor137c: :LEU2 construct at the YOR137c
locus was con¢rmed by Southern blotting. The heterozygous diploid
vyor137c : :LEU2/YOR137c was sporulated, and tetrads were dis-
sected.
2.4. Biochemical methods
Yeast plasma membrane was puri¢ed from glucose-starved and
glucose fermenting cells by di¡erential and sucrose gradient centrifu-
gation [10]. ATPase activity was assayed at pH 6.5 with ATP concen-
trations from 0.8 to 6 mM [23]. The apparent Km and Vmax were
extrapolated from double-reciprocal plots ¢tted using a standard
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Fig. 1. Chromosomal location and subcloning of the YOR137c
gene. Restriction map of part of chromosome XV [31]. Positions of
the ORFs are indicated by arrows. DNA subclones used to test the
ability to complement the apa7 mutation are represented by thin
horizontal lines. Restriction enzyme sites: E, EcoRI; H, HindIII; N,
NsiI; P, PstI; X, XhoI.
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least-squares method. Similar values (within 10%) were obtained with
two di¡erent plasma membrane preparations isolated independently.
Protein concentration was determined by the method of Bradford [24]
using the Bio-Rad protein assay reagent and bovine IgG as standard.
Plasma membrane proteins were separated by SDS-PAGE on 8%
acrylamide using the Laemmli system [25]. The Mab16 monoclonal
antibody against the yeast ATPase [26] was used in immunoblot.
Western blot with second antibody conjugated to alkaline phospha-
tase (Bio-Rad) was as described [27].
3. Results and discussion
The YOR137c gene was cloned by its ability to suppress the
phenotype of the apa7-1 mutant strain when carried on a
centromeric plasmid. This strain exhibits slow growth in
SD3.0 medium, as a consequence of a diminished plasma
membrane H-ATPase activity level [9]. After transformation
of the mutant strain with a YCp50-based yeast genomic li-
brary, we recovered a plasmid (pAN7-100) containing a 6.5-
kb insert corresponding to a segment of chromosome XV
(Fig. 1). Subcloning experiments con¢ned the complementary
activity to a 3.3-kb BglII-PstI fragment containing the
YOR137c gene (Fig. 1). The YOR137c gene encodes a 71.8-
kDa membrane protein of unknown function [28,29].
A YOR137c deletion was created by removal of a fragment
of the protein coding sequence and replacement of this seg-
ment with the selectable marker LEU2 (see Section 2). This
vyor137c: :LEU2 construct was used to transform a diploid
yeast strain. The transformant diploid was sporulated and
tetrads dissected. In all 10 four-spore tetrads studied, the
Leu segregants exhibited slow growth in SD3.0 and reduced
ATPase activity. An example of the growth phenotype and
ATPase activity level of a representative tetrad is shown in
Fig. 2. The possibility that YOR137c was an extragenic sup-
pressor of apa7-1 was discarded by crossing a vyor137-
c : :LEU2 haploid segregant with the strain H114 (apa7-1)
and analyzing the segregation of the low pH sensitivity phe-
notype conferred by these mutations. In all cases (12 asci
analyzed), the low pH-sensitive phenotype segregated at a
ratio of 4:0, suggesting that the cloned gene corresponds to
the APA7 locus.
To study the biochemical phenotype of the vyor137c::LEU2
allele, we ¢rst examined plasma membrane Pma1 levels by
Western analysis of puri¢ed plasma membrane preparations
from isogenic wild-type and vyor137c : :LEU2 strains using
speci¢c anti-ATPase antibody (Fig. 3). The level of Pma1
was similar in both strains. This suggests that the reduced
ATPase activity of the vyor137c : :LEU2 mutant is not due
to a defect in the synthesis or intracellular sorting of Pma1.
Since vyor137c : :LEU2 does not a¡ect the ATPase protein
level, we explored the e¡ect of the mutation on enzyme acti-
vation by glucose (Fig. 4). After 15 min incubation with glu-
cose, a six-fold increase in ATPase activity was observed in
the wild-type strain, while under the same conditions, glucose
caused a three-fold activation of the mutant strain.
To further characterize the e¡ect of the vyor137c : :LEU2
mutation on the enzyme activation by glucose, we determined
the kinetic properties of the enzyme in puri¢ed plasma mem-
brane of the wild-type and mutant strains obtained from glu-
cose-starved and glucose fermenting cells (Fig. 5). In mutant
enzyme, the typical Vmax increase caused by glucose was not
observed, whereas the Km decrease was not signi¢cantly di¡er-
ent from that of the enzyme from wild-type cells. This result
suggests that the glucose-triggered Vmax increase in this en-
zyme is mediated by the YOR137c gene product.
Recent ¢ndings suggest that the Km decrease produced by
glucose is a ubiquitin-dependent process [30]. Here we show
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Fig. 2. Growth phenotype and ATPase activity of a representative
tetrad from the heterozygous diploid vyor137c : :LEU2/YOR137c.
Cells were plated in media containing glucose media bu¡ered at pH
6.0 (SD6.0), SD6.0 minus leucine (3Leu) or glucose media bu¡ered
at pH 3.0 (SD3.0) and incubated at 30‡C for 36 h. ATPase activity
was measured in puri¢ed plasma membrane from glucose fermenting
cells. Values are the average of two di¡erent experiments. The spe-
ci¢c activity di¡ered by less than 10%.
Fig. 3. Analysis of the Pma1 level in YOR137c and vyor137c::LEU2
strains plasma membranes. SDS-polyacrylamide gel electrophoresis
(lanes 1 and 2) and Western blot analysis (lanes 3 and 4) of puri¢ed
plasma membrane from YOR137c (lanes 1 and 3) and vyor137-
c : :LEU2 (lanes 2 and 4) strains. Each lane contains 5 Wg protein.
The position of pre-stained molecular weight standards is indicated.
Fig. 4. Glucose activation of ATPase from wild-type and vyor137-
c : :LEU2 mutant strains. At time zero, glucose was added to wild-
type (a) or to the vyor137c : :LEU2 mutant strain (b) ; samples were
taken at the times indicated and plasma membrane puri¢ed. The
ATPase activity of the puri¢ed membrane fraction was determined
at pH 6.5 with 2 mM ATP. Similar values (within 10%) were ob-
tained in two independent experiments.
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that the glucose-induced Vmax increase is mediated by an ap-
parently unrelated gene; it thus seems that two independent
mechanisms are needed to achieve glucose activation of the
ATPase. The fact that deletion of YOR137c abolishes the
glucose-triggered Vmax increase suggests that YOR137c prob-
ably has an upregulating role in the Vmax increase produced
by glucose addition to yeast cells. Although the speci¢c func-
tion of YOR137c is unknown, this study provides a starting
point for further characterization of H-ATPase activation.
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Fig. 5. E¡ect of glucose on kinetics of plasma membrane ATPase
from wild-type and vyor137c : :LEU2 mutant strain. Wild-type (a)
and vyor137c : :LEU2 (b) were incubated with (GF) or without glu-
cose (GS) before homogenization. The ATPase activity of puri¢ed
plasma membrane was assayed at pH 6.5 with the indicated concen-
tration of ATP. The apparent Km (mM) and the Vmax (Wmol/min/
mg protein) calculated from the ¢gure are indicated. Similar values
(within 10%) were obtained with two independently obtained plasma
membrane preparations.
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